StockData
BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc. (BBIO) stock

BBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 3/30
$78.01+1.21 (+1.58%)

Close on Nov 18, 2026Market cap $15.20BP/E –Yield –

BridgeBio Pharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

BridgeBio Pharma's market cap was $15.53B on Nov 11, 2026, against $13.87B a year earlier. Over the last 5 years it ranged from $1.01B to $15.67B, with a median of $5.24B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$15.53B+5.4%
2025Dec 31, 2025$14.73B+184.1%
2024Dec 31, 2024$5.19B-26.2%
2023Dec 29, 2023$7.03B+517.6%
2022Dec 30, 2022$1.14B-53.6%
2021Dec 31, 2021$2.45B-71.8%
2020Dec 31, 2020$8.71B+111.8%
2019Dec 31, 2019$4.11B–

More BridgeBio Pharma figures

See a number that looks wrong?